What is ResMed's total revenue?

ResMed (RMD) reported total revenue of $1.43B in Q1 2026.

How has ResMed's total revenue changed year-over-year?

ResMed's total revenue increased by 10.8% year-over-year, from $1.29B to $1.43B.

What is the long-term trend for ResMed's total revenue?

Over 3 years (2022 to 2025), ResMed's total revenue has grown at a 12.9% compound annual growth rate (CAGR), from $3.58B to $5.15B.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

ResMed RMD Total Revenue

Discontinued — last reported Q3 '26

Total Revenue at other companies

Eli LillyLLY

$19.8B+55.5%

Five Point Holdings, Inc.FPH

$13.58M+3.2%

Inspire Medical SystemsINSP

$204.58M+1.6%

Viemed Healthcare, Inc.VMD

$75.41M+27.5%

LivaNovaLIVN

$362.26M+14.3%

AdaptHealthAHCO

$819.8M+5.4%

Segments

By product

See full

Devices$1.47B+8.8%

Sleep And Breathing Health$1.26B+11.5%

Masks and other$1.05B+15.5%

Residential Care Software$170.89M+6.0%

By geography

See full

Global revenue$1.43B+10.8%

U.S., Canada and Latin America$818.67M+9.3%

Combined Europe, Asia and other markets$441.84M+15.9%

By segment

See full

Sleep and Breathing Health$1.26B+11.5%

Residential Care Software$170.89M+6.0%

Other financials

Income statement

See full

Gross profit$891.0M+16.3%

Operating income$499.8M+17.3%

Net income$398.7M+9.2%

EPS (diluted)$2.74+10.5%

Balance sheet

See full

Cash & equivalents$1.7B+78.0%

Total debt$1.1B+29.8%

Total equity$6.5B+17.1%

Total assets$8.8B+16.1%

Cash flow

See full

Operating cash flow$554.1M-4.2%

CapEx$33.7M+61.8%

Free cash flow$520.5M-6.7%

Valuation

See full

Market cap$29.05B-22.6%

Enterprise value$28.5B-23.3%

P/E19.1×-7.7×

P/S5.3×-2.0×

Profitability

See full

Gross margin61.6%+2.8pp

Operating margin34.2%+2.1pp

Net margin27.4%+1.3pp

FCF margin31.7%+0.4pp

Returns & leverage

See full

Return on equity25.2%-0.6pp

Debt / equity0.2×0.0×

Current ratio3×-0.4×

Where this comes from

Reported directly by ResMed in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: ResMed’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about ResMed's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ResMed's total revenue?: ResMed (RMD) reported total revenue of $1.43B in Q1 2026.
How has ResMed's total revenue changed year-over-year?: ResMed's total revenue increased by 10.8% year-over-year, from $1.29B to $1.43B.
What is the long-term trend for ResMed's total revenue?: Over 3 years (2022 to 2025), ResMed's total revenue has grown at a 12.9% compound annual growth rate (CAGR), from $3.58B to $5.15B.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.